genemen biotech (suzhou) co., ltd.
genemen, a stock-holding company is mainly engaged in industrial development of biotechnological drugs. it has built the suzhou engineering technology research center for recombinant protein medicine, which produces products like recombinant protein drugs and monoclonal antibody, covering the therapy of oncology, tissue regeneration, gastroenterology, immunology, etc.
core team members are experienced in biological product development for more than 20 years, and they have received several prestigious awards.
